Latest News

Contact:
Scott Milligan
312.622.3301

When Bear Stearns imploded in mid-March, the ripple effect reverberated throughout the financial markets, including healthcare equipment financing.

“Many tax exempt facilities have shut down,” says Peter Myhre, CEO of MarCap Corp., a leading healthcare financing company. “The market clearly thinks there is more risk today than a year ago.”

Yet Myhre feels that plenty of opportunities exist. Lenders such as MarCap place considerable weight on management strength when making decisions on financing a new healthcare venture. “Track record is really critical,” he says. “With cancer centers, we also look for multiple owners, including physicians, a hospital and a developer. Having ownership drives success.”

According to Sean Lazard, M.D, an analyst for Lazard Capital Markets, hospitals “may be having difficulties building new wings, cancer centers, surgical centers, etc., for which the hospital wishes to issue bonds,” but it is “easier to get loans to buy equipment.”

“An off balance sheet structure, such as the joint venture model Accelitech employs, is attractive,” Myhre says, “because a hospital can still bring new technology to its market while reducing risk. Joint ventures, like the ones Accelitech develops, bring physicians together with the hospital to better serve patients in their given market by providing technology to which they might not otherwise have access.”

About Accelitech LLC

Accelitech LLC is a developer of stereotactic radiosurgery programs. Headquartered in Chicago, IL., Accelitech is a privately-held company with broad experiences and resources in healthcare law, finance, development, clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. National in scope, Accelitech has sites and projects under development throughout the United States.

For additional information about Accelitech and the services provided contact Scott Milligan by calling (312) 622-3301.